{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:45:19Z","timestamp":1773301519912,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.172","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T04:27:55Z","timestamp":1467088075000},"page":"514-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Trimetazidine attenuates the acute inflammatory response induced by Novolimus eluting bioresorbable coronary scaffold implantation"],"prefix":"10.1016","volume":"220","author":[{"given":"Khalid I.","family":"Amber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najah R.","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashaer M.","family":"Muhammad-Baqir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina A.","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-0120","authenticated-orcid":false,"given":"Hayder A.","family":"Al-Aubaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.172_bb0005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00392-005-0299-x","article-title":"Current understanding of coronary in-stent restenosis","volume":"94","author":"Schiele","year":"2005","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1373\/clinchem.2004.032656","article-title":"Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement","volume":"50","author":"Rittersma","year":"2004","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.ijcard.2016.06.172_bb0015","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","article-title":"Inflammation and restenosis in the stent era","volume":"22","author":"Welt","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0020","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.mehy.2007.01.090","article-title":"Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects","volume":"69","author":"Li","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.CIR.91.5.1397","article-title":"Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24hours after successful PTCA","volume":"91","author":"Rodriguez","year":"1995","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2016.06.172_bb0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(03)00852-0","article-title":"Restenosis intra-stent: balloon angioplasty versus elective stenting (RIBS) investigators. A randomized comparison ofrepeat stenting with balloon angioplasty in patients with in-stent restenosis","volume":"42","author":"Alfonso","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.172_bb0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jcin.2009.04.003","article-title":"The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents","volume":"2","author":"Kukreja","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCINTERVENTIONS.109.859173","article-title":"Bioabsorbable coronary stents","volume":"2","author":"Ormiston","year":"2009","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0050","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.110.970772","article-title":"Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis six-month clinical and imaging outcomes","volume":"122","author":"Serruys","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0055","first-page":"e11","article-title":"Bioresorbable vascular scaffold use in a case of in-stent restenosis","volume":"103","author":"Cadrin-Tourigny","year":"2014","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0065","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/ATVBAHA.111.231795","article-title":"Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk","volume":"31","author":"Welsh","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"18","key":"10.1016\/j.ijcard.2016.06.172_bb0070","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehq251","article-title":"Recommendations for the use of cardiac troponin measurement in acute cardiac care","volume":"31","author":"Thygesen","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Lipid Assessment Trial Italian Network (LATIN) investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.atherosclerosis.2009.10.033","article-title":"Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction","volume":"210","author":"Matsui","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","volume":"152","author":"Monk","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijcard.2016.06.172_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4236\/wjcs.2013.35035","article-title":"Trimetazidine and cellular response in cardiopulmonary bypass","volume":"3","author":"Martins","year":"2013","journal-title":"WJCS"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2013.01.016","article-title":"Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure","volume":"59","author":"Dedkova","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00005344-199312000-00008","article-title":"Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits","volume":"22","author":"Williams","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.208.203","article-title":"Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine","volume":"208","author":"Kuralay","year":"2006","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/heart.84.1.83","article-title":"Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis","volume":"84","author":"Hojo","year":"2000","journal-title":"Heart"},{"issue":"22","key":"10.1016\/j.ijcard.2016.06.172_bb0115","article-title":"Biodegradable vascular scaffold ABSORB BVS\u2122\u2014scientific evidence and methods of implantation. Post\u0119py w Kardiologii Interwencyjnej","volume":"9","author":"Rzeszutko","year":"2013","journal-title":"Adv. Interv. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2006.04.034","article-title":"Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease","volume":"98","author":"Ramadan","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1590\/S0066-782X2012005000066","article-title":"Trimetazidine and inflammatory response in coronary artery bypass grafting","volume":"99","author":"Martins","year":"2012","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MCA.0000000000000128","article-title":"The effect of dalteparin versus unfractionated heparin on the levels of troponin I and creatine kinase isoenzyme MB in elective percutaneous coronary intervention: a multicenter study","volume":"25","author":"Zhang","year":"2014","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/hrt.2006.107524","article-title":"Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention","volume":"93","author":"Bonello","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10103-012-1142-z","article-title":"Effect of the intravascular low energy laser illumination during percutaneous coronary intervention on the inflammatory process in vascular wall","volume":"28","author":"Derkacz","year":"2013","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.ijcard.2016.06.172_bb0145","first-page":"1791","article-title":"The cardioprotective potential of trimetazidine in myocardial ischemia reperfusion injury","volume":"6","author":"Hadi","year":"2015","journal-title":"JPBCS"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2009.07.030","article-title":"Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a","volume":"208","author":"Speidl","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.06.172_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-010-0471-7","article-title":"Inflammatory response to percutaneous coronary intervention in stable coronary artery disease","volume":"31","author":"Munk","year":"2011","journal-title":"J. Thromb. Thrombolysis"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T18:27:33Z","timestamp":1536604053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316311846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":31,"alternative-id":["S0167527316311846"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.172","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimetazidine attenuates the acute inflammatory response induced by Novolimus eluting bioresorbable coronary scaffold implantation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}